Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 621640 of 20,252 grants

Active NON-SBIR/STTR RPGS
Maximizing the efficacy of MDM2 inhibitor therapy for MDM2-amplified glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

PROJECT DESCRIPTION/ABSTRACT MDM2 amplification occurs in 3.5% of all malignancies and in approximately 10% of several highly aggressive malignancies, including glioblastoma. MDM2...

$4.58M
USD
Active OTHER RESEARCH-RELATED
Deciphering the role of pH regulator Slc4a4 in glioma progression
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2026

PROJECT SUMMARY. Malignant glioma is a devastating brain cancer with no improvements in prognosis over decades. One key mechanism for glioma progression is the dynamic metabolic co...

$1.35M
USD
Active OTHER RESEARCH-RELATED
Targeted Radionuclide Therapy to Enhance the Efficacy of CAR T Cells Against Neuroblastoma
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Quaovi Sodji, MD, PhD is a Tenure track Assistant Professor in the Department of Human Oncology at the University of Wisconsin School of Medicine and Publi...

$1.6M
USD
Active TRAINING, INDIVIDUAL
Exploring the Relationship Between the Oral Microbiome and Fatigue in Individuals with Breast Cancer: A Longitudinal Study
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2026

PROJECT ABSTRACT Fatigue, the most distressing symptom, affects between 60-90% of all individuals with breast cancer. The prevalence of fatigue increases to 80-96% when these indiv...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Local Administration of Particle-Anchored Cytokines as a Safe and Effective Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Virginia Polytechnic Inst and St Univ United States 2024 – 2026

PROJECT SUMMARY / ABSTRACT The primary objective of this proposal is to develop a localized cancer immunotherapy using particle-anchored cytokines with prolonged intratumoral reten...

$3.8M
USD
Active NON-SBIR/STTR RPGS
Mitochondrial Metabolism and Cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Transformation of normal cells to cancer cells involves complex changes influenced by oncogenes, inactivation of tumor suppressors, and disrupted signaling...

$6.08M
USD
Active NON-SBIR/STTR RPGS
The role of long noncoding RNAs in acute myeloid leukemia
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Over the past 40-years, the standard therapy for acute myeloid leukemia (AML), a highly fatal blood cancer, remains a combination of chemo drugs such as cy...

$4.15M
USD
Active NON-SBIR/STTR RPGS
A20 and Tumor Immune Responses
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

Abstract Immunosuppressive and homeostatic mechanisms prevent immune cells and tissues from eliminating solid tumors, limiting the efficacy of anti-tumor immunity. Precise dissecti...

$5.53M
USD
Active TRAINING, INDIVIDUAL
A novel immunotherapy for pancreatic cancer using micro-RNA-29a
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2028

Project Summary Pancreatic cancer is the third leading cause of cancer-related deaths in the United States with a 5-year survival rate of 12%. Despite the success of immune-modulat...

$539.7K
USD
Active TRAINING, INDIVIDUAL
Factors Impacting Global Health: The Importance of Individualized Treatment Goals for Black Breast Cancer Survivors
NATIONAL CANCER INSTITUTE Trustees of Indiana University United States 2024 – 2027

Project Summary/ Abstract: This F31 award will allow Kelsey Sinclair (PI) the research training that will advance her toward her goal of becoming an independent cancer multimorbidi...

$377.9K
USD
Active TRAINING, INDIVIDUAL
Deciphering inv3/t(3;3) Myeloid Leukemia Vulnerabilities via Proteogenomics and N-terminal Proteomics
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2027

PROJECT SUMMARY The overall objective of this proposal is to develop and apply novel proteogenomic approaches to identify therapeutic vulnerabilities of chromosome 3 rearranged mye...

$447.3K
USD
Active TRAINING, INDIVIDUAL
Quantitative magnetic resonance imaging for non-invasive breast cancer therapy using physics-informed neural networks.
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2026

Project Summary My overarching goal is to become a biomedical engineer capable of advancing minimally invasive procedures through medical imaging and machine learning. To achieve t...

$408.6K
USD
Active TRAINING, INDIVIDUAL
Aberrant activation of epidermal growth factor receptor signaling drives programming of an immunosuppressive brain tumor microenvironment in glioblastoma
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Glioblastoma (GBM) is the most common primary malignant brain tumor with a dismal prognosis that lacks effective therapeutic strategies. While the advent o...

$446.7K
USD
Active NON-SBIR/STTR RPGS
Determinants of response to cancer immunotherapy
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT While immunotherapy is transforming cancer treatment, the majority of patients do not achieve durable responses. We have been studying response and resista...

$10.03M
USD
Active NON-SBIR/STTR RPGS
Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT Prostate cancer (PCa) is a clinically and molecular heterogenous disease, with distinct subtypes. These subtypes are associated with characteristic genom...

$7.11M
USD
Active NON-SBIR/STTR RPGS
Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY Neoadjuvant and perioperative chemoimmunotherapy are the standard of care for the treatment of patients with resectable non-small cell lung cancer (NSCLC). Unfortun...

$6.7M
USD
Active OTHER RESEARCH-RELATED
Mechanisms of NK cell activation and immune-editing of leukemia
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2027

PROJECT SUMMARY Candidate: Dr. Jennifer Foltz’s doctoral and post-doctoral training has focused on improving natural killer (NK) cell therapy, a type of innate lymphocyte that has...

$1.94M
USD
Active NON-SBIR/STTR RPGS
A Role of Multilevel Healthcare Access Dimensions in Ovarian Cancer Disparities
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2026

ABSTRACT Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system. In 2021, there were 21,410 new cases of OC and 13,770 deaths. Remarkable p...

$5.27M
USD
Active NON-SBIR/STTR RPGS
Novel regulation of the CDK4/Cdh1/Pin1 signaling axis for targeted breast cancer therapies
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2027

Project Summary/Abstract: The anaphase-promoting complex/Cyclosome (APC/C) is a well-defined multi-subunit E3 ubiquitin ligase that regulates targeted cell cycle regulators for deg...

$2.49M
USD
Active NON-SBIR/STTR RPGS
Dose Linear Energy Transfer Volume Histogram and Dosimetric Seed Spot Analysis in Spot Scanning Proton Therapy
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Radiation therapy may induce severe adverse events (AEs), and result in significant detriment to patients’ quality of life, especially in head and neck, su...

$6.14M
USD